Peggy J Farnham

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 14

Top Venues

Nucleic acids research

Science advances

Cancers

Nature communications

University of Southern California

Yale University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern California

United States

Professor and Chair :: Biochemistry and Molecular Biology

University of California Davis

United States

Professor/Associate Director of the Genome Center :: Pharmacology/Genome Center

University of Wisconsin Madison

United States

Assistant Professor, Associate Professor, Professor :: McArdle Laboratory for Cancer Research

Education History

Yale University

United States

PHD :: Molecular Biophysics and Biochemistry

Publications

Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon M Schreiner, Nathan R Zemke, Peggy J Farnham
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic acids research 52 (12) (2024)
Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon M Schreiner, Nathan R Zemke, Peggy J Farnham
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic acids research 52 (12) (2024)
Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon M Schreiner, Nathan R Zemke, Peggy J Farnham
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic acids research (2024)
Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon M Schreiner, Nathan R Zemke, Peggy J Farnham
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic acids research 52 (12) (2024)
Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon M Schreiner, Nathan R Zemke, Peggy J Farnham
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters. Nucleic acids research 52 (12) (2024)
Yi-Tsung Lu, Tong Xu, Maheen Iqbal, Tien-Chan Hsieh, Zhifei Luo, Gangning Liang, Peggy J Farnham, Suhn K Rhie, Amir Goldkorn
FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. Cancers 14 (7) (2022)
Zhifei Luo, Peggy J Farnham
Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells. PloS one 15 (2) (2020)
null null, Jill E Moore, Michael J Purcaro, Henry E Pratt, Charles B Epstein, Noam Shoresh, Jessika Adrian, Trupti Kawli, Carrie A Davis, Alexander Dobin, Rajinder Kaul, Jessica Halow, Eric L Van Nostrand, Peter Freese, David U Gorkin, Yin Shen, Yupeng He, Mark Mackiewicz, Florencia Pauli-Behn, Brian A Williams, Ali Mortazavi, Cheryl A Keller, Xiao-Ou Zhang, Shaimae I Elhajjajy, Jack Huey, Diane E Dickel, Valentina Snetkova, Xintao Wei, Xiaofeng Wang, Juan Carlos Rivera-Mulia, Joel Rozowsky, Jing Zhang, Surya B Chhetri, Jialing Zhang, Alec Victorsen, Kevin P White, Axel Visel, Gene W Yeo, Christopher B Burge, Eric Lécuyer, David M Gilbert, Job Dekker, John L Rinn, Eric M Mendenhall, Joseph R Ecker, Manolis Kellis, Robert J Klein, William S Noble, Anshul Kundaje, Roderic Guigó, Peggy J Farnham, J Michael Cherry, Richard M Myers, Bing Ren, Brenton R Graveley, Mark B Gerstein, Len A Pennacchio, Michael Paul Snyder, Bradley E Bernstein, Barbara Wold, Ross Cameron Hardison, Thomas R Gingeras, John A Stamatoyannopoulos, Nishigandha Phalke
Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583 (7818) (2020)
Daniel J Mullen, Chunli Yan, Diane S Kang, Beiyun Zhou, Zea Borok, Crystal Nicole Marconett, Peggy J Farnham, Ite A Offringa, Suhn Kyong Rhie
TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. PLoS genetics 16 (9) (2020)
Suhn Kyong Rhie, Andrew A Perez, Fides D Lay, Shannon M Schreiner, Jiani Shi, Jenevieve Polin, Peggy J Farnham
A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome. Nature communications 10 (1) (2019)
Zhifei Luo, Suhn Kyong Rhie, Peggy J Farnham
The Enigmatic HOX Genes: Can We Crack Their Code? Cancers 11 (3) (2019)
Yuyang Qian, Lei Zhang, Mingyang Cai, Hongxia Li, Heming Xu, Hongzhen Yang, Zhongfang Zhao, Suhn Kyong Rhie, Peggy J Farnham, Jiandang Shi, Wange Lu
The prostate cancer risk variant rs55958994 regulates multiple gene expression through extreme long-range chromatin interaction to control tumor progression. Science advances 5 (7) (2019)
Suhn Kyong Rhie, Shannon M Schreiner, Heather Witt, Chris Armoskus, Fides D Lay, Adrian Camarena, Valeria N Spitsyna, Yu Guo, Benjamin P Berman, Oleg V Evgrafov, James A Knowles, Peggy J Farnham
Using 3D epigenomic maps of primary olfactory neuronal cells from living individuals to understand gene regulation. Science advances 4 (12) (2018)
Yu Guo, Andrew A Perez, Dennis J Hazelett, Gerhard A Coetzee, Suhn Kyong Rhie, Peggy J Farnham
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome biology 19 (1) (2018)
GiNell Elliott, Chibo Hong, Xiaoyun Xing, Xin Zhou, Daofeng Li, Cristian Coarfa, Robert J A Bell, Cecile L Maire, Keith L Ligon, Mahvash Sigaroudinia, Philippe Gascard, Thea D Tlsty, R Alan Harris, Leonard C Schalkwyk, Misha Bilenky, Jonathan Mill, Peggy J Farnham, Manolis Kellis, Marco A Marra, Aleksandar Milosavljevic, Martin Hirst, Gary D Stormo, Ting Wang, Joseph F Costello
Intermediate DNA methylation is a conserved signature of genome regulation. Nature communications 6 (2015)

Peggy J Farnham.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peggy J Farnham